MedPath

sing blood level measurement to gauge the targeting dose of Ketamine infusion in treatment refractory depression.

Not Applicable
Conditions
Single Low-Dose Ketamine Injection in Treating Major Depression
Registration Number
JPRN-UMIN000023588
Lead Sponsor
Taipei Veterans General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
6
Inclusion Criteria

Not provided

Exclusion Criteria

1.Major medical conditions (e.g., head injury, epilepsy, severe renal and cancer). 2.Pregnancy 3.Use of CNS intoxicant (eq. cocaine, cannabis, opiates) within the previous 24 hours. 4.Symptoms of substance abuse/dependence(except nicotine dependence) within 6 months 5.Lifetime use of ketamine or phencyclidine (PCP) 6.Diagnosis of psychosis or bipolar disorder 7.current NMDA antagonist medication (eq. Amantadine, Rimantadine, Lamotrigine, Memantine, Dextromethorphan) 8.Actively trying to commit suicide even in a hospital setting 9.Current homicide risk

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath